ACE2 and COVID-19: Importantly, this variation in the expression of ACE2 and TMPRSS2 in human pancreata was explained by another study that described ACE2 to be weakly present in the islets of control individuals; however, in COVID‐19 patients, ACE2 was expressed in the beta cells of some of them, while it was only expressed in the fibroblasts for others.22